NEW YORK, August 29, 2018 /PRNewswire/ -- The global progressive multifocal leukoencephalopathy treatment market is likely to reach a valuation of US$ 150.5 Mn by 2026 by the end of 2026 Progressive multifocal leukoencephalopathy (PML) is a rare, fatal disease that causes conti...
from PR Newswire: //https://ift.tt/2N21w5c
No comments:
Post a Comment